Buparlisib, 99.90%
cas: 944396-07-0 — see every product listed under this CAS number, including other names
Buparlisib, 99.90% (CAS 944396-07-0) is a chemical reagent available from Chemat. Available pack sizes: 50 mg, 500 mg, 5 mg, 100 mg, 200 mg, 10 mg, 10mM/1mL. Offered by: MedChemExpress.
| brand | MedChemExpress |
|---|---|
| catalog number | HY-70063-50 mg |
| cas | 944396-07-0 |
| size | 50 mg |
| availability | In stock |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| MedChemExpress | 50 mg | 886.26 Pln | |
| MedChemExpress | 500 mg | 2711.35 Pln | |
| MedChemExpress | 5 mg | 463.66 Pln | |
| MedChemExpress | 100 mg | 1174.19 Pln | |
| MedChemExpress | 200 mg | 1559.64 Pln | |
| MedChemExpress | 10 mg | 640.13 Pln | |
| MedChemExpress | 10mM/1mL | 500.81 Pln |
properties
| delivery time | 1-2 weeks |
|---|---|
| purity | 99.90% |
BKM120 is an aminopyridine that is 4-(trifluoromethyl)pyridin-2-amine substituted at position 5 by a 2,6-di(morpholin-4-yl)pyrimidin-4-y group. A selective PI3K inhibitor with anti-tumour properties. It has a role as an antineoplastic agent and an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor. It is an organofluorine compound, an aminopyridine, an aminopyrimidine and a member of morpholines.
Source: ChEBI
| Molecular formula | C18H21F3N6O2 |
|---|---|
| Molecular weight | 410.4 g/mol |
| IUPAC name | 5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine |
| InChIKey | CWHUFRVAEUJCEF-UHFFFAOYSA-N |
| SMILES | C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4 |
Computed by PubChem (NCBI)
Synonyms:
Buparlisib, buparlisibum, 5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine, Buparlisib (BKM120), Buparlisib [INN], 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-Pyridinamine, 5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine, 5-[2,6-Di(Morpholin-4-Yl)pyrimidin-4-Yl]-4-(Trifluoromethyl)pyridin-2-Amine, BUPARLISIB [WHO-DD], 5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine